Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction (Q44090725)

29 November 2017

Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction (English)

1 reference

29 November 2017

myocardial infarction

1 reference

1 reference

1

1 reference

29 November 2017

4

J H Gurwitz

1 reference

29 November 2017

J V Tu

2

1 reference

29 November 2017

G M Anderson

3

1 reference

29 November 2017

J P Clark

5

1 reference

29 November 2017

P Lau

6

1 reference

29 November 2017

J P Szalai

7

1 reference

29 November 2017

K Sykora

8

1 reference

29 November 2017

C D Naylor

9

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

29 November 2017

1 reference

29 November 2017

356

1 reference

29 November 2017

9230

1 reference

29 November 2017

639-644

1 reference

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

Pitfalls in nonrandomized outcomes studies. The case of incidental appendectomy with open cholecystectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

Prevalence and mortality rate of congestive heart failure in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

Benefit of beta-blockers for heart failure: proven in 1999

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

The exclusion of the elderly and women from clinical trials in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902606-4

7 January 2021

10.1016/S0140-6736(00)02606-4

Identifiers

DOI

1 reference

29 November 2017

1 reference